Blog
About

15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome.

      The Journal of clinical investigation

      Sequence Analysis, DNA, Proteolysis, genetics, Protein Processing, Post-Translational, Protein Multimerization, metabolism, Proteasome Endopeptidase Complex, Point Mutation, Podocytes, Pedigree, pathology, diagnosis, Nephrotic Syndrome, Models, Molecular, Lung Diseases, Interstitial, Integrin alpha3, Infant, Humans, Glycosylation, Glomerular Mesangium, Genetic Association Studies, Gene Expression, Female, Fatal Outcome, Endoplasmic Reticulum, Cells, Cultured, Base Sequence, Antigens, CD29, Antigens, CD151

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Integrins are transmembrane αβ glycoproteins that connect the extracellular matrix to the cytoskeleton. The laminin-binding integrin α3β1 is expressed at high levels in lung epithelium and in kidney podocytes. In podocytes, α3β1 associates with the tetraspanin CD151 to maintain a functional filtration barrier. Here, we report on a patient homozygous for a novel missense mutation in the human ITGA3 gene, causing fatal interstitial lung disease and congenital nephrotic syndrome. The mutation caused an alanine-to-serine substitution in the integrin α3 subunit, thereby introducing an N-glycosylation motif at amino acid position 349. We expressed this mutant form of ITGA3 in murine podocytes and found that hyperglycosylation of the α3 precursor prevented its heterodimerization with β1, whereas CD151 association with the α3 subunit occurred normally. Consequently, the β1 precursor accumulated in the ER, and the mutant α3 precursor was degraded by the ubiquitin-proteasome system. Thus, these findings uncover a gain-of-glycosylation mutation in ITGA3 that prevents the biosynthesis of functional α3β1, causing a fatal multiorgan disorder.

          Related collections

          Author and article information

          Journal
          10.1172/JCI64100
          3533548
          23114595

          Comments

          Comment on this article